TrapEase下腔静脉滤器在单一医疗系统10年应用中的结局
回顾性分析2003年4月至2013年1月在单一机构接受TrapEase下腔静脉滤器的594例患者,随访中位3.6个月,82.3%死亡,突破性肺栓塞1.5%,滤器骨折13.3%,复发深静脉血栓18.7%。作者认为滤器骨折率似乎较高,但无游离骨折片或远处迁移。
要点
- 594例接受TrapEase滤器患者中,随访期间82.3%死亡,105例存活且滤器在位。
- 582例临床随访中突破性肺栓塞9例(1.5%),复发深静脉血栓109例(18.7%)。
- 128例含滤器影像中滤器骨折17例(13.3%),无游离骨折片或远处迁移。
核心结论
- 多数接受TrapEase滤器的患者在随访期间死亡,可能因为操作者选择对已知终末期疾病患者植入永久滤器。
- 滤器骨折率似乎较高,但无游离骨折片或远处迁移的病例。
- 尽管双篮设计理论上可有效预防血栓迁移,但突破性肺栓塞率与其他滤器相当。
研究设计与样本
- 回顾性研究,纳入2003年4月至2013年1月在单一机构接受TrapEase滤器的所有患者,共594例(女性278例,平均年龄68.9±13.6岁,范围19.2-96.3岁),研究持续88个月,中位临床随访3.6个月(范围0-148.3个月)。
主要发现
- 随访期间594例中489例(82.3%)死亡,105例存活且滤器在位。
- 582例有临床随访的患者中发生突破性肺栓塞9例(1.5%)。
- 128例影像包含滤器的患者中发生滤器骨折17例(13.3%)。
- 39例有可用计算机断层扫描的患者中8例滤器内充盈缺损提示血栓或栓子(20.5%),包括2例完全性腔静脉闭塞。
- 582例有临床随访的患者中复发深静脉血栓109例(18.7%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To retrospectively investigate the safety, efficacy, and complications associated with TrapEase inferior vena cava filters. METHODS: All patients who received a TrapEase filter at a single institution between April 2003 and January 2013 were identified, and outcomes were reviewed and analyzed. RESULTS: During the study period, 594 patients (278 women; mean age, 68.9 ± 13.6 years; range, 19.2-96.3 years) received a TrapEase filter. The duration of this study was 88 months, with a median clinical follow-up of 3.6 months (range, 0-148.3 months). During follow-up, 489 of 594 patients (82.3%) died and 105 remained alive with filters in situ. Nine cases of breakthrough pulmonary embolism occurred among the 582 patients with clinical follow-up (1.5%). Among 128 patients with imaging that contained the filter, there were 17 cases of filter fracture (13.3%). Of the 39 patients with available computed tomography scans, eight had filling defects within the filter suggestive of thrombus or embolus (20.5%), including two patients with complete caval occlusion. Recurrent deep vein thrombosis occurred in 109 out of 582 patients (18.7%) with clinical follow-up. CONCLUSIONS: Most patients who received TrapEase filters died during follow-up, possibly because operators chose to implant a permanent filter in patients with known terminal illnesses. The filter fracture rate seemed to be high, but there were no instances of free fracture fragment or distant migration. Although the filter may theoretically be effective in preventing thrombus migration owing to the double basket design, pulmonary embolism breakthrough rates were comparable with rates seen with other filters.
引用
- Tsui B, Moon E, Zheng J, et al. Outcomes of the TrapEase inferior vena cava filter over 10 years at a single health care system. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29937150. doi:10.1016/j.jvsv.2018.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。